Estrella Immunopharma, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Estrella Immunopharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Estrella Immunopharma, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 1.55 USD/shares, a 93.1% decline year-over-year.
  • Estrella Immunopharma, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.27 USD/shares, a 99.3% increase year-over-year.
  • Estrella Immunopharma, Inc. annual Earnings Per Share, Basic for 2024 was -0.27 USD/shares, a 99.3% increase from 2023.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $1.55 -$21 -93.1% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-27
Q1 2024 $20.60 $0 +$8.12 +99.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $12.50 $0 +$16.30 +99.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$4 -$2 +$32.60 +94.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$36 $22.40 +$22.50 Apr 1, 2023 Jun 30, 2023 10-K 2024-09-27
Q1 2023 -$59 -$8 -$8 -40550% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$51 -$16 Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$34 -$33 -3368% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $0 +$2.04 +99% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$2 Jan 6, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.